Rate-Control or Rhythm-Contol: Where do we stand?

Atrial fibrillation is the most common sustained rhythm disturbance and its prevalence is increasing worldwide due to the progressive aging of the population. Current guidelines clearly depict the gold standard management of acute symptomatic atrial fibrillation but the best-long term approach for f...

Full description

Bibliographic Details
Main Authors: Testa L, Trotta G, Dello Russo A, Casella M, Pelargonio G, Andreotti F, Bellocci F
Format: Article
Language:English
Published: Elsevier 2005-10-01
Series:Indian Pacing and Electrophysiology Journal
Subjects:
Online Access:http://www.ipej.org/0504/testa.htm
id doaj-86eca0274a404e2bbbe490d5f2e6f6b0
record_format Article
spelling doaj-86eca0274a404e2bbbe490d5f2e6f6b02020-11-25T01:24:47ZengElsevierIndian Pacing and Electrophysiology Journal0972-62922005-10-0154296304Rate-Control or Rhythm-Contol: Where do we stand?Testa LTrotta GDello Russo ACasella MPelargonio GAndreotti FBellocci FAtrial fibrillation is the most common sustained rhythm disturbance and its prevalence is increasing worldwide due to the progressive aging of the population. Current guidelines clearly depict the gold standard management of acute symptomatic atrial fibrillation but the best-long term approach for first or recurrent atrial fibrillation is still debated with regard to quality of life, risk of new hospitalizations, and possible disabling complications, such as thromboembolic stroke, major bleeds and death. Some authors propose that regaining sinus rhythm in all cases, thus re-establishing a physiologic cardiac function not requiring a prolonged antithrombotic therapy, avoids the threat of intracranial or extracranial haemorrhages due to Vitamin K antagonists or aspirin. On the contrary, advocates of a rate control approach with an accurate antithrombotic prophylaxis propose that such a strategy may avoid the risk of cardiovascular and non cardiovascular side effects related to antiarrhythmic drugs. This review aims to explore the state of our knowledge in order to summarize evidences and issues that need to be furthermore clarified. http://www.ipej.org/0504/testa.htmatrial fibrillationrate controlrhythm controlsecondary prevention
collection DOAJ
language English
format Article
sources DOAJ
author Testa L
Trotta G
Dello Russo A
Casella M
Pelargonio G
Andreotti F
Bellocci F
spellingShingle Testa L
Trotta G
Dello Russo A
Casella M
Pelargonio G
Andreotti F
Bellocci F
Rate-Control or Rhythm-Contol: Where do we stand?
Indian Pacing and Electrophysiology Journal
atrial fibrillation
rate control
rhythm control
secondary prevention
author_facet Testa L
Trotta G
Dello Russo A
Casella M
Pelargonio G
Andreotti F
Bellocci F
author_sort Testa L
title Rate-Control or Rhythm-Contol: Where do we stand?
title_short Rate-Control or Rhythm-Contol: Where do we stand?
title_full Rate-Control or Rhythm-Contol: Where do we stand?
title_fullStr Rate-Control or Rhythm-Contol: Where do we stand?
title_full_unstemmed Rate-Control or Rhythm-Contol: Where do we stand?
title_sort rate-control or rhythm-contol: where do we stand?
publisher Elsevier
series Indian Pacing and Electrophysiology Journal
issn 0972-6292
publishDate 2005-10-01
description Atrial fibrillation is the most common sustained rhythm disturbance and its prevalence is increasing worldwide due to the progressive aging of the population. Current guidelines clearly depict the gold standard management of acute symptomatic atrial fibrillation but the best-long term approach for first or recurrent atrial fibrillation is still debated with regard to quality of life, risk of new hospitalizations, and possible disabling complications, such as thromboembolic stroke, major bleeds and death. Some authors propose that regaining sinus rhythm in all cases, thus re-establishing a physiologic cardiac function not requiring a prolonged antithrombotic therapy, avoids the threat of intracranial or extracranial haemorrhages due to Vitamin K antagonists or aspirin. On the contrary, advocates of a rate control approach with an accurate antithrombotic prophylaxis propose that such a strategy may avoid the risk of cardiovascular and non cardiovascular side effects related to antiarrhythmic drugs. This review aims to explore the state of our knowledge in order to summarize evidences and issues that need to be furthermore clarified.
topic atrial fibrillation
rate control
rhythm control
secondary prevention
url http://www.ipej.org/0504/testa.htm
work_keys_str_mv AT testal ratecontrolorrhythmcontolwheredowestand
AT trottag ratecontrolorrhythmcontolwheredowestand
AT dellorussoa ratecontrolorrhythmcontolwheredowestand
AT casellam ratecontrolorrhythmcontolwheredowestand
AT pelargoniog ratecontrolorrhythmcontolwheredowestand
AT andreottif ratecontrolorrhythmcontolwheredowestand
AT belloccif ratecontrolorrhythmcontolwheredowestand
_version_ 1725117120819232768